Improving Outcomes After Frontline Therapy.

Thanks to rapid innovation and unmatched dedication from investigators and oncology care providers, patients with cancer are living longer than ever before, motivating further research into optimizing patient outcomes and quality of life after success with frontline therapy.

In an interview with ONCOLOGY[R], Elias Jabbour, MD, a professor of medicine in the Department of Leukemia, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center in Houston, discussed his contributions to the field of medicine and how innovation has paid off in spades.

"Leukemia, in particular, is really evolving at a very high speed. Every year, we...